https://www.marketscreener.com/quote/stock/PROVECTUS-BIOPHARMACEUTIC-15657688/news/PROVECTUS-ANNOUNCES-GRANT-OF-ORPHAN-DRUG-DESIGNATION-IN-U-S-TO-PV-10-FOR-TREATMENT-OF-OCULAR-MELANO-27998022/?utm_source=telegram&utm_medium=social&utm_campaign=share